QUESTCOR PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: QUESTCOR PHARMACEUTICALS INC, 10-Q, 2000-11-13
Next: LONDON PACIFIC GROUP LTD, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           7,263
<SECURITIES>                                     3,512
<RECEIVABLES>                                      448
<ALLOWANCES>                                     (200)
<INVENTORY>                                        150
<CURRENT-ASSETS>                                   618
<PP&E>                                           3,418
<DEPRECIATION>                                 (1,324)
<TOTAL-ASSETS>                                  18,312
<CURRENT-LIABILITIES>                            8,383
<BONDS>                                            638
                                0
                                      5,081
<COMMON>                                        66,178
<OTHER-SE>                                    (62,779)
<TOTAL-LIABILITY-AND-EQUITY>                    18,312
<SALES>                                          1,581
<TOTAL-REVENUES>                                 3,050
<CGS>                                            1,592
<TOTAL-COSTS>                                   14,308
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 564
<INCOME-PRETAX>                               (10,964)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (10,964)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (10,964)
<EPS-BASIC>                                   (0.08)
<EPS-DILUTED>                                   (0.08)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission